<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="migraine/PMC6681503/results/search/disease/results.xml">
  <result pre="The aim of this study was to investigate whether pediatric" exact="migraine" post="is associated with vitamin D deficiency and the effect"/>
  <result pre="of vitamin D therapy on the frequency, duration, severity of" exact="migraine" post="attacks, and Pediatric Migraine Disability Assessment (PedMIDAS). Materials and"/>
  <result pre="hormone, alkaline phosphatase, and 25-OH vitamin D of 92 pediatric" exact="migraine" post="patients. The patients were divided into two groups: Group"/>
  <result pre="therapy. Migraine severity measured by the visual analog scale (VAS)," exact="migraine" post="frequency, and duration as well as scores on the"/>
  <result pre="D levels. In addition, pre- and posttreatment pedMIDAS scores, VAS," exact="migraine" post="frequency, and duration were compared with baseline values. Results:"/>
  <result pre="D deficiency (vitamin D levels &amp;lt; 10 ng/mL). Migraine frequency," exact="migraine" post="duration, and PedMIDAS scores were significantly higher in the"/>
  <result pre="0.001). After vitamin D therapy at sixth months of supplementation," exact="migraine" post="duration was reported statistically significant shorter ( p &amp;lt;"/>
  <result pre="reported statistically significant shorter ( p &amp;lt; 0.001) and the" exact="migraine" post="frequency, VAS scores, and pedMIDAS scores were statistically significant"/>
  <result pre="&amp;lt; 0.001). Conclusion: We found a marked correlation between pediatric" exact="migraine" post="and vitamin D levels. Vitamin D therapy was beneficial"/>
  <result pre="and vitamin D levels. Vitamin D therapy was beneficial in" exact="migraine" post="pediatric patients. childhood migraine vitamin D pedMIDAS 1. Introduction"/>
  <result pre="Vitamin D therapy was beneficial in migraine pediatric patients. childhood" exact="migraine" post="vitamin D pedMIDAS 1. Introduction Migraine is a neurologic"/>
  <result pre="pedMIDAS 1. Introduction Migraine is a neurologic condition characterized by" exact="hypersensitivity" post="to auditory, olfactory, visual, and cutaneous stimuli; vomiting and"/>
  <result pre="stimuli; vomiting and nausea; and severe headache. The pathophysiology of" exact="migraine" post="is not completely understood; however, the commonly reported hypotheses"/>
  <result pre="indicates that various brain disorders, such as epilepsy, Alzheimer’s disease," exact="multiple sclerosis," post="depression, autism, and schizophrenia, and some immune-mediated disorders, such"/>
  <result pre="and schizophrenia, and some immune-mediated disorders, such as type I" exact="diabetes mellitus," post="rheumatoid arthritis, inflammatory bowel diseases, and systemic lupus erythematosus,"/>
  <result pre="and some immune-mediated disorders, such as type I diabetes mellitus," exact="rheumatoid arthritis," post="inflammatory bowel diseases, and systemic lupus erythematosus, may arise"/>
  <result pre="type I diabetes mellitus, rheumatoid arthritis, inflammatory bowel diseases, and" exact="systemic lupus erythematosus," post="may arise due to vitamin D imbalance [ 8]."/>
  <result pre="I diabetes mellitus, rheumatoid arthritis, inflammatory bowel diseases, and systemic" exact="lupus erythematosus," post="may arise due to vitamin D imbalance [ 8]."/>
  <result pre="9]. Few recent studies have demonstrated that tension-type headache and" exact="migraine" post="may be related to low vitamin D serum levels"/>
  <result pre="17, 18]. In this study, we aimed to clarify whether" exact="migraine" post="and vitamin D deficiency are related in pediatric patients"/>
  <result pre="Materials and Methods This retrospective study included patients with episodic" exact="migraine" post="who were admitted to the pediatric neurology outpatient clinic"/>
  <result pre="of chronic diseases (e.g., liver, skin, metabolic, renal, gastrointestinal, or" exact="bone disease;" post="psychiatric disorder; cerebral palsy; and cognitive/intellectual disability), those with"/>
  <result pre="liver, skin, metabolic, renal, gastrointestinal, or bone disease; psychiatric disorder;" exact="cerebral palsy;" post="and cognitive/intellectual disability), those with diseases causing immobilization and"/>
  <result pre="and age. The patients were evaluated with regard to their" exact="migraine" post="duration and frequency. The duration of the migraine headache"/>
  <result pre="to their migraine duration and frequency. The duration of the" exact="migraine" post="headache was determined as hours in the day. The"/>
  <result pre="migraine headache was determined as hours in the day. The" exact="migraine" post="frequency was determined as the number of migraine attacks"/>
  <result pre="day. The migraine frequency was determined as the number of" exact="migraine" post="attacks within one month. Serum levels of 25-OH vitamin"/>
  <result pre="&amp;gt;20 ng/mL were group 2. The PedMIDAS and VAS scores;" exact="migraine" post="frequency; migraine duration; and 25-OH vitamin D, Ca, P,"/>
  <result pre="were group 2. The PedMIDAS and VAS scores; migraine frequency;" exact="migraine" post="duration; and 25-OH vitamin D, Ca, P, ALP, PTH"/>
  <result pre="significant. 4. Results A total of 92 pediatric patients with" exact="migraine" post="(67 girls (72.8%) and 25 (27.2%) boys) were included"/>
  <result pre="The median patient age was 12.6 (range, 6–18) years. The" exact="migraine" post="frequency, migraine duration, and pedMIDAS scores were found to"/>
  <result pre="patient age was 12.6 (range, 6–18) years. The migraine frequency," exact="migraine" post="duration, and pedMIDAS scores were found to be significantly"/>
  <result pre="there was no difference between the groups in terms of" exact="migraine" post="severity. Table 1 presents the patients’ characteristics. Vitamin D"/>
  <result pre="of the patients are given in Table 2. The median" exact="migraine" post="severity score was 6.9. There was no difference in"/>
  <result pre="severity score was 6.9. There was no difference in the" exact="migraine" post="severity between girls and boys. There were also no"/>
  <result pre="and boys. There were also no significant differences in the" exact="migraine" post="severity, frequency, and migraine duration as well as in"/>
  <result pre="also no significant differences in the migraine severity, frequency, and" exact="migraine" post="duration as well as in the PedMIDAS scores between"/>
  <result pre="of migraine. We found statistically significant negative correlations between the" exact="migraine" post="frequency, migraine duration, PedMIDAS score, and the vitamin D"/>
  <result pre="We found statistically significant negative correlations between the migraine frequency," exact="migraine" post="duration, PedMIDAS score, and the vitamin D levels ("/>
  <result pre="( p &amp;lt; 0.001). However, we observed no association between" exact="migraine" post="severity and 25-OH vitamin D levels Table 3. Migraine"/>
  <result pre="&amp;lt; 0.001). However, we found no considerable association between the" exact="migraine" post="severity and vitamin D level, between duration of migraine"/>
  <result pre="the migraine severity and vitamin D level, between duration of" exact="migraine" post="and vitamin D level, or between the patients with"/>
  <result pre="patients in group 1 reported statistically significant shorter durations of" exact="migraine" post="after vitamin D therapy ( p &amp;lt; 0.001). After"/>
  <result pre="therapy ( p &amp;lt; 0.001). After 6-month of therapy, the" exact="migraine" post="frequency and duration as well as the VAS scores"/>
  <result pre="cause chronic pain and headache disorders, specifically tension-type headache and" exact="migraine" post="[ 14, 25, 26]. Through our survey, we observed"/>
  <result pre="notable decreases in the PedMIDAS score as well as the" exact="migraine" post="duration, frequency, and severity in the patients who received"/>
  <result pre="levels of vitamin D, such as hypoparathyroidism, bone fractures, and" exact="multiple sclerosis," post="are more frequent at levels &amp;lt;20 ng/mL [ 3,"/>
  <result pre="and apoptosis [ 14, 33]. Moreover, in chronic pain and" exact="migraine" post="attacks, the levels of substance P, the calcitonin gene-related"/>
  <result pre="factors as well oxidative stress. Vitamin D deficiency can cause" exact="secondary hyperparathyroidism." post="Some studies have reported that the levels of PTH,"/>
  <result pre="serotonin synthesis, which is usually observed in tension-type headache and" exact="migraine" post="[ 12]. Vitamin D inhibits matrix metalloproteinase 9 (MMP-9)"/>
  <result pre="but could not propose a correlation between vitamin D and" exact="migraine" post="[ 41]. Thys-Jacobs et al. stated that supplemental calcium"/>
  <result pre="and vitamin D administration produced a sudden reduction in the" exact="migraine" post="duration and frequency [ 13]. The results could be"/>
  <result pre="which in turn may have led to a decrease in" exact="migraine" post="headaches [ 13, 15]. O’Brien et al. also documented"/>
  <result pre="PTH in patients with migraines, which could be due to" exact="secondary hyperparathyroidism" post="that was treated by optimal levels of vitamin D"/>
  <result pre="in patients with migraines, which could be due to secondary" exact="hyperparathyroidism" post="that was treated by optimal levels of vitamin D"/>
  <result pre="that vitamin D therapy with amitriptyline reduces the recurrence of" exact="migraine" post="attacks in pediatric patients with migraine [ 17]. To"/>
  <result pre="reduces the recurrence of migraine attacks in pediatric patients with" exact="migraine" post="[ 17]. To the best of our knowledge, this"/>
  <result pre="suffering from migraine. We detected significant negative relationships between the" exact="migraine" post="frequency and serum vitamin D levels, as well as"/>
  <result pre="frequency and serum vitamin D levels, as well as between" exact="migraine" post="duration and PedMIDAS scores (r = −0.591, p &amp;lt;"/>
  <result pre="no association was observed ( p = 0.128) between the" exact="migraine" post="severity and vitamin D levels. After treatment with vitamin"/>
  <result pre="severity and vitamin D levels. After treatment with vitamin D," exact="migraine" post="severity (VAS scores), migraine duration, migraine frequency, and PedMIDAS"/>
  <result pre="levels. After treatment with vitamin D, migraine severity (VAS scores)," exact="migraine" post="duration, migraine frequency, and PedMIDAS scores were significantly decreased"/>
  <result pre="treatment with vitamin D, migraine severity (VAS scores), migraine duration," exact="migraine" post="frequency, and PedMIDAS scores were significantly decreased in the"/>
  <result pre="vitamin D levels were not compared between patients diagnosed with" exact="migraine" post="and a healthy control group. 6. Conclusions We found"/>
  <result pre="group. 6. Conclusions We found a significant relationship between pediatric" exact="migraine" post="and vitamin D levels. We also demonstrated that vitamin"/>
  <result pre="publication of this article. References References 1. Schwedt T.J. Chronic" exact="migraine" post="BMJ 2014 348 1416 10.1136/bmj.g1416 24662044 2. Antonucci R."/>
  <result pre="of the International Classification of Headache Disorders for diagnosis of" exact="migraine" post="and tension-type headache in children Dev. Med. Child Neurol."/>
  <result pre="19619241 15. Thys-Jacobs S. Vitamin D and calcium in menstrual" exact="migraine" post="Headache 1994 34 544 546 10.1111/j.1526-4610.1994.hed3409544.x 8002332 16. O’Brien"/>
  <result pre="Effect of vitamin D therapy in addition to amitriptyline on" exact="migraine" post="attacks in pediatric patients Braz. J. Med. Biol. Res."/>
  <result pre="ratings of headache pain in a randomizedcontrolled clinical trial with" exact="migraine" post="patients Pain 2001 93 185 190 10.1016/S0304-3959(01)00315-3 11427330 22."/>
  <result pre="practice recommendations for native vitamin D therapy in children with" exact="chronic kidney disease" post="Stages 2–5 and on dialysis Nephrol. Dial. Transplant 2017"/>
  <result pre="chronic tension-type headache, musculoskeletal pain, and vitamin D deficiency: Is" exact="osteomalacia" post="responsible for both headache and musculoskeletal pain? Ann. Indian."/>
  <result pre="Ebrahimi H. Haghdoost F. Saadatnia M. Vitamin D status in" exact="migraine" post="patients: A case-control study Biomed. Res. Int. 2014 514782"/>
  <result pre="between the vitamin D level of the patients and the" exact="migraine" post="severity, migraine duration, migraine frequency, and PedMIDAS score. 25-OH"/>
  <result pre="vitamin D level of the patients and the migraine severity," exact="migraine" post="duration, migraine frequency, and PedMIDAS score. 25-OH vitamin D"/>
  <result pre="level of the patients and the migraine severity, migraine duration," exact="migraine" post="frequency, and PedMIDAS score. 25-OH vitamin D r *"/>
  <result pre="medicina-55-00321-t004_Table 4 Table 4 Relationship between Vitamin D levels and" exact="migraine" post="severity, duration, frequency, and PedMIDAS score. 25-OH vitamin D,"/>
 </snippets>
</snippetsTree>
